Alnylam Pharmaceuticals Inc

NASDAQ:ALNY   3:59:58 PM EDT
132.61
+1.04 (+0.79%)
Earnings Announcements

Alnylam Pharmaceuticals Reports First Quarter 2021 Financial Results

Published: 04/29/2021 12:20 GMT
Alnylam Pharmaceuticals Inc (ALNY) - Alnylam Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Period Activity.
Alnylam Pharmaceuticals Inc - Qtrly GAAP Net Loss per Common Share $1.71.
Alnylam Pharmaceuticals Inc - Qtrly Non-GAAP Net Loss per Common Share $1.64.
Revenue is expected to be $193.06 Million
Adjusted EPS is expected to be -$1.60

Next Quarter Revenue Guidance is expected to be $214.12 Million
Next Quarter EPS Guidance is expected to be -$1.57

More details on our Analysts Page.